ProCE Banner Activity

Evolving Role of Biologic Therapies for β-Thalassemia

Slideset Download

Download this slideset for an expert-curated overview of emerging therapies for β-thalassemia including review of the latest clinical data leading to the recent approval of the biologic agent luspatercept for transfusion-dependent disease.

Released: December 03, 2020

Expiration: December 02, 2021

No longer available for credit.

Share

Faculty

Sujit Sheth

Sujit Sheth, MD

Professor
Department of Pediatrics
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Sujit Sheth, MD

Professor
Department of Pediatrics
Weill Cornell Medicine
New York, New York